ライフサイエンスコーパス: arterial stiffness

1 may be assessed by determining the degree of arterial stiffness.

2 n pregnancy has lasting effects on offspring arterial stiffness.

3 althy postmenopausal women is beneficial for arterial stiffness.

4 etin-2 as a link between kidney fibrosis and arterial stiffness.

5 l approach to ameliorate atherosclerosis and arterial stiffness.

6 erial blood pressure, a surrogate marker for arterial stiffness.

7 genes regulate intrinsic SM tone and thereby arterial stiffness.

8 Vo2 without altering endothelial function or arterial stiffness.

9 lower pulmonary vascular resistance and less arterial stiffness.

10 or carbohydrates on endothelial function and arterial stiffness.

11 ressure, forearm blood flow, or estimates of arterial stiffness.

12 tween residential surrounding greenspace and arterial stiffness.

13 flavones are inversely associated with lower arterial stiffness.

14 dial viability ratio were measured to assess arterial stiffness.

15 ve velocity-a clinically relevant measure of arterial stiffness.

16 om fish may improve endothelial function and arterial stiffness.

17 k-favorably affects endothelial function and arterial stiffness.

18 rtension, in part through kidney disease and arterial stiffness.

19 dial artery applanation tonometry to measure arterial stiffness.

20 ides information on both atherosclerosis and arterial stiffness.

21 asonography, and radial tonometry to measure arterial stiffness.

22 complex interaction between ventricular and arterial stiffness.

23 lations of several biomarkers to measures of arterial stiffness.

24 icular hypertrophy and evidence of increased arterial stiffness.

25 and radial applanation tonometry to measure arterial stiffness.

26 tact parathyroid hormone predicted increased arterial stiffness.

27 rmation for understanding the development of arterial stiffness.

28 its hallmark abnormality: increased central arterial stiffness.

29 sfunction are also associated with increased arterial stiffness.

30 predict changes in central pulse pressure or arterial stiffness.

31 d noradrenaline increase aortic and systemic arterial stiffness.

32 lse pressure provides a surrogate measure of arterial stiffness.

33 in adiposity indices through adolescence on arterial stiffness.

34 ve better performance over AI r in assessing arterial stiffness.

35 ts of long-term magnesium supplementation on arterial stiffness.

36 vs three [0.2%]; p=0.0007), retinopathy and arterial stiffness (13 [1.0%] vs four [0.3%]; p=0.0016),

37 femoral pulse-wave velocity (cfPWV) measured arterial stiffness 2, 12, 24, and 42 weeks post-ART init

38 ivity in other conditions is associated with arterial stiffness, a marker of cardiovascular risk.

39 t of asymmetric dimethyl arginine in causing arterial stiffness, a phenomenon which has been linked w

40 With the exception of arterial stiffness, all these findings are opposite in d

41 ting serum lipids, microvascular reactivity, arterial stiffness, ambulatory blood pressure, and marke

42 inol ameliorates endothelial dysfunction and arterial stiffness among patients without chronic kidney

43 Two indirect measures of arterial stiffness, an ankle brachial index greater than

44 Arterial stiffness, an independent determinant of cardio

45 this relationship is unclear but may involve arterial stiffness, an independent risk marker for CVD m

46 ufficiency will be associated with increased arterial stiffness and abnormal vascular function.

47 Direct measures of arterial stiffness and atherosclerosis included central

48 Whole body insulin sensitivity, arterial stiffness and blood pressure were also assessed

49 umans have examined the relationship between arterial stiffness and blood pressure.

50 ss (13 [1.0%] vs four [0.3%]; p=0.0016), and arterial stiffness and cardiovascular autonomic neuropat

51 In adults, NAFLD is a determinant of arterial stiffness and cardiovascular risk, independent

52 t this novel approach significantly improves arterial stiffness and central hemodynamics, which might

53 significant treatment effects were noted for arterial stiffness and central mean or 24-h ambulatory b

54 the temporal relationship of elevated BP to arterial stiffness and elasticity.

55 D insufficiency is associated with increased arterial stiffness and endothelial dysfunction in the co

56 ensitivity, adipose tissue inflammation, and arterial stiffness and exerts a beneficial shift in gut

57 Increased arterial stiffness and higher plasma natriuretic peptide

58 Increased arterial stiffness and impaired endothelial function are

59 Arterial stiffness and impaired nitric oxide (NO) bioava

60 EECP treatment reduces arterial stiffness and improves wave reflection characte

61 Arterial stiffness and inflammation are associated with

62 pulse wave velocity (PWV) reflects increased arterial stiffness and is an established cardiovascular

63 ong-term exposure to outdoor greenspace with arterial stiffness and its progression over time.

64 The contribution of immune activation to arterial stiffness and its reversibility in human immuno

65 Arterial stiffness and left ventricular hypertrophy may

66 Arterial stiffness and mean arterial pressure variably c

67 We studied the association between arterial stiffness and mild-to-moderate CKD and albuminu

68 ogenesis and maintenance of hypertension and arterial stiffness and more novel cardiovascular risk fa

69 There are sex differences in arterial stiffness and neural control of blood pressure

70 of calibrated tonometry and pulsed Doppler, arterial stiffness and pulsatile hemodynamics were asses

71 study has evaluated the association between arterial stiffness and risk of depressive symptoms.

72 uggest distinct polygenic susceptibility for arterial stiffness and salt-sensitive hypertension in Da

73 patients and looked for associations between arterial stiffness and SCD-related vascular complication

74 based studies have evaluated the genetics of arterial stiffness and separate mean and pulsatile compo

75 data for exercise training's improvement of arterial stiffness and system inflammation and reduction

76 These data, which include direct measures of arterial stiffness and thickness, suggest that higher in

77 The association between arterial stiffness and various cardiovascular outcomes (

78 induce an amelioration in vascular function, arterial stiffness and vascular remodelling by improving

79 Vascular function, arterial stiffness and vascular remodelling were evaluat

80 ring adolescence was associated with greater arterial stiffness and was further aggravated by an unfa

81 Various measures of arterial stiffness and wave reflection have been propose

82 Increased arterial stiffness and wave reflections are present in m

83 se pressure (bPP), aoPP, and all measures of arterial stiffness and wave reflections were higher in H

84 sitive patients with AAV are associated with arterial stiffness and whether treatment with valaciclov

85 ed preload, and decreases in blood pressure, arterial stiffness, and afterload as well, thereby impro

86 It causes significant arterial stiffness, and as yet, no clinical therapy exis

87 e levels as well as markers of inflammation, arterial stiffness, and atherosclerosis.

88 ed by a forward pressure wave and related to arterial stiffness, and augmentation pressure (AP), thou

89 ted dilatation (FMD) of the brachial artery, arterial stiffness, and blood pressure.

90 Blood pressure, arterial stiffness, and endothelial function in the peri

91 opathy, cardiovascular autonomic neuropathy, arterial stiffness, and hypertension.

92 This cell population is associated with arterial stiffness, and its expansion is attenuated with

93 Arterial stiffness, and its progression with age, is an

94 Associations between serum phosphate, arterial stiffness, and left ventricular (LV) mass sugge

95 ng heart contractility, myocyte hypertrophy, arterial stiffness, and systemic resistance.

96 icate that AASV is associated with increased arterial stiffness, and that stiffness correlates with t

97 nifedipine, and placebo on proteinuria, BP, arterial stiffness, and various cardiovascular biomarker

98 iastolic volume/BSA, mass/BSA, and pulmonary arterial stiffness, and with decreasing EF, from 0.89 to

99 ative stress, high rates of hypertension and arterial stiffness; and those without constitutive expre

100 We prospectively measured arterial stiffness (aortic pulse wave velocity [aPWV]) a

101 Vascular function and arterial stiffness are important markers of cardiovascul

102 LV systolic and arterial stiffness are increased, which may exacerbate l

103 Elevation in plasma ET-1 and increases in arterial stiffness are potential important mechanisms un

104 Increases in arterial stiffness are related to inflammation, and are

105 her studies examining the potential value of arterial stiffness as a screening tool to guide initiati

106 s index and, in a subpopulation of patients, arterial stiffness as measured by pulse wave velocity.

107 also documented the prognostic importance of arterial stiffness (AS) in various populations as an ind

108 24 wk in overweight and obese adults reduces arterial stiffness, as estimated by a decrease in PWVc-f

109 associations with myocardial infarction and arterial stiffness, as well as coronary artery calcifica

110 orrelated independently with the severity of arterial stiffness assessed by pulse wave velocity.

111 ole of angiopoietin-2 in the pathogenesis of arterial stiffness associated with CKD.

112 This study compared indices of arterial stiffness at rest and during exercise in subjec

113 IV-infected participants alone, the adjusted arterial stiffness at week 44 tended to be lower in thos

114 d whether this might reflect consequences of arterial stiffness, atherosclerosis, or both is unknown.

115 r system--platelet and endothelial function, arterial stiffness, atherosclerosis, oxidative stress, i

116 history of AF, liver/kidney transplantation, arterial stiffness, atherosclerotic plaques in the aorta

117 hickness, 0.01 mm (-0.01 to 0.03), p = 0.36; arterial stiffness (augmentation index), -1.1% (-2.5 to

118 %; 95% CI: 0.83%, 2.1%; P = 0.003), systemic arterial stiffness (augmentation index: -2.24%; 95% CI:

119 rom the lower body, resulting from increased arterial stiffness, augments central aortic pressure and

120 Flow-mediated dilation (FMD), arterial stiffness, blood pressure, heart rate, and seru

121 Second, effects on arterial stiffness, blood pressure, serum lipids, and pl

122 carotid intima-media thickness (a measure of arterial stiffness), brachial artery reactivity (both fl

123 trength-training does not lead to changes in arterial stiffness but to vascular remodeling.

124 unction by flow-mediated dilation (FMD), and arterial stiffness by applanation tonometry.

125 maging and echocardiography, and we assessed arterial stiffness by carotid-femoral pulse wave velocit

126 RhoBTB1 fully corrected the hypertension and arterial stiffness by improving vasodilator function.

127 Greenspace exposure may protect against arterial stiffness by promoting physical activity, foste

128 f the brachial artery, and evaluated central arterial stiffness by pulse-wave analysis.

129 ort a role for the endothelium in regulating arterial stiffness by release of vasoactive mediators.

130 function (primary outcome), blood pressure, arterial stiffness, cardiac autonomic function, platelet

131 cause of age-associated increases in central arterial stiffness, cardiovagal BRS was expressed with b

132 Arterial stiffness (carotid to femoral pulse wave veloci

133 measurements between the ages 9-17 years and arterial stiffness (carotid to femoral pulse wave veloci

134 sma lipids, glucose, C-reactive protein, and arterial stiffness [carotid-femoral pulse wave velocity

135 in improving arterial endothelial function, arterial stiffness, central and systemic blood pressure

136 ual flavonoid intakes and direct measures of arterial stiffness, central blood pressure, and atherosc

137 ally improve central hemodynamics and reduce arterial stiffness compared with conventional beta-block

138 ive protein levels, homocysteine levels, and arterial stiffness compared with those without LV hypert

139 scular endothelial dysfunction and increased arterial stiffness contribute to increased cardiovascula

140 Arterial stiffness contributes to CVD risk in CKD.

141 In summary, arterial stiffness correlates with albuminuria but not w

142 Whether arterial stiffness correlates with mild-to-moderate CKD

143 Any gender differences in arterial stiffness could influence pulse pressure (PP),

144 ction and arterial remodelling improved, and arterial stiffness decreased in all the arteries, sugges

145 In cross-sectional analyses, arterial stiffness did not associate with CKD (defined b

146 y (2-8 repeated measures, median of 5), and arterial stiffness estimates of 3 large arteries (ultras

147 Arterial stiffness, flow-mediated dilation (FMD), nitrog

148 109 +/- 9 mmHg, P = 0.049) without impacting arterial stiffness, FMD, GMD, or NO.

149 king blood pressure and different aspects of arterial stiffness from childhood onward, with an aim of

150 , and magnetic resonance imaging, we related arterial stiffness, GFR, urinary albumin excretion, and

151 Conversely, reduced arterial stiffness has been associated with increased su

152 gy and therapy of this syndrome, the role of arterial stiffness has been frequently overlooked.

153 Because arterial stiffness has independent prognostic value for

154 of endothelin-1 (ET-1) in the regulation of arterial stiffness has not been investigated.

155 At 44 weeks, arterial stiffness improved more in those with greater d

156 hip between elevated blood pressure (BP) and arterial stiffness in a biracial (black-white) cohort of

157 sease activity, endothelial dysfunction, and arterial stiffness in a cohort of rheumatoid arthritis (

158 iposity levels are associated with increased arterial stiffness in adolescence and any mediation effe

159 adolescence to adulthood) is associated with arterial stiffness in adulthood.

160 id synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E(-/-) mice and rab

161 ion, vascular smooth muscle dysfunction, and arterial stiffness in at least two models of hypertensio

162 ing medication on vascular calcification and arterial stiffness in CKD remain uncertain.

163 rs (ARBs) improves left ventricular mass and arterial stiffness in early-stage chronic kidney disease

164 e reduces left ventricular mass and improves arterial stiffness in early-stage CKD.

165 gents that target the NO pathway in reducing arterial stiffness in HFpEF.

166 (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Popula

167 sociated with blood pressure and measures of arterial stiffness in nondemented individuals.

168 antigens, is quantitatively associated with arterial stiffness in older life.

169 medullin, and homocysteine concentrations to arterial stiffness in participants in the Framingham Hea

170 e if vitamin K supplementation might improve arterial stiffness in patients in CKD, we conducted a pa

171 te the relationship between inflammation and arterial stiffness in patients with antineutrophil cytop

172 not vitamin K supplementation could improve arterial stiffness in patients with CKD is unknown.

173 ction, and the therapeutic options to reduce arterial stiffness in patients with CKD.

174 , and aerobic exercise interventions improve arterial stiffness in previously sedentary middle-aged a

175 We assessed arterial stiffness in SCD patients and looked for associ

176 for quantitative trait loci (QTLs) affecting arterial stiffness in six-week old F2 (Dahl S x R)-inter

177 carbonate improves LV mass, LV function, or arterial stiffness in stage 3 nondiabetic CKD.

178 We assessed arterial stiffness in subjects with Sri Lankan CKDu, in

179 Whether cognition is influenced by arterial stiffness in the absence of vascular disease re

180 NAFLD is only associated with increased arterial stiffness in the presence of the "high risk" me

181 nthesis could ameliorate atherosclerosis and arterial stiffness in transgenic mice and rabbits.

182 t nitric oxide (NO) acting locally regulates arterial stiffness in vivo, and the aim of this experime

183 dex and augmentation pressure, correlates of arterial stiffness, in a cohort of elderly men in the Bo

184 Arterial stiffness increased at 12 weeks compared with 3

185 Furthermore, because arterial stiffness increases left ventricular afterload,

186 Arterial stiffness increases with age and contributes to

187 Ventricular and arterial stiffness increases with age in both sexes, but

188 was to ascertain if NAFLD is associated with arterial stiffness, independent of cardiometabolic facto

189 Arterial stiffness index (ASI) is a non-invasive measure

190 The arterial stiffness index was correspondingly increased (

191 trast, ADMA was significantly related to the arterial stiffness index.

192 Women with HDP had elevated arterial stiffness indexes and greater prevalence of chr

193 Central blood pressure and arterial stiffness indexes were measured at baseline and

194 deposition changes over time and generalized arterial stiffness indicated a relationship between the

195 y improved endothelium-dependent dilatation, arterial stiffness, intima media thickness and blood pre

196 the setting of diabetes mellitus, promoting arterial stiffness irrespective of calcification.

197 Arterial stiffness is a key determinant of cardiovascula

198 Arterial stiffness is an important determinant of cardio

199 Future studies should evaluate whether arterial stiffness is an important mechanism leading to

200 Arterial stiffness is an important risk factor for cardi

201 Arterial stiffness is an independent predictor of cardio

202 se risk as prior work demonstrates increased arterial stiffness is associated with elevated systolic

203 Although arterial stiffness is believed to underlie, in part, the

204 Whether arterial stiffness is influenced by lifetime fiber intak

205 owever, the performance of AI r in assessing arterial stiffness is limited.

206 This study sought to demonstrate that arterial stiffness is probably underestimated in patient

207 with age in nondemented individuals and that arterial stiffness is strongly associated with the progr

208 wave velocity (PWV), a noninvasive index of arterial stiffness, is a predictor of the longitudinal c

209 A high ABI, a marker of lower extremity arterial stiffness, is associated with CVD events and mo

210 ity-dwelling older adults, aPWV, a marker of arterial stiffness, is associated with higher CV mortali

211 reflections and PP amplification, but not of arterial stiffness, is observed when hypertension is stu

212 Arterial stiffness leads to LV mass through nonatheroscl

213 ion was evaluated by 24-hour blood pressure, arterial stiffness, low (LF)- and high (HF)-frequency he

214 Arterial stiffness may contribute to late-life depressio

215 pathophysiological processes that determine arterial stiffness may help guide therapeutic approaches

216 Endothelial function and arterial stiffness may therefore serve as important phys

217 Primary outcomes were 1) arterial stiffness measured by aortic pulse wave velocit

218 s of cardiovascular disease, suggesting that arterial stiffness, measured via carotid-femoral pulse w

219 Noninvasive arterial stiffness measurement was performed in a subset

220 ardiovascular evaluation, including imaging, arterial stiffness measurements, and biochemical studies

221 s to reduce it, and clinical applications of arterial stiffness measurements.

222 to examine the associations between baseline arterial stiffness measures (exposure variables) and inc

223 Arterial stiffness measures and mean and pulsatile compo

224 , noninvasive methods for the measurement of arterial stiffness, mechanisms leading to aortic stiffen

225 Arterial stiffness modulates ventricular loading conditi

226 Cardiovascular (24-h blood pressure, arterial stiffness), neurobehavioral (subjective sleepin

227 hange BP (office BP and 24-h ambulatory BP), arterial stiffness, nitric oxide, endothelin 1, or blood

228 o assess the effects of indirect measures of arterial stiffness on cognitive performance.

229 with lanthanum over 96 weeks did not affect arterial stiffness or aortic calcification compared with

230 but no significant difference in the odds of arterial stiffness (OR, 1.07; 95% CI, 0.63-1.84; P = .80

231 patients, such as impaired vision, increased arterial stiffness, or decreased kidney function.

232 tation did not improve endothelial function, arterial stiffness, or inflammation.

233 vestigate the effects of oral astaxanthin on arterial stiffness, oxidative stress, and inflammation i

234 xanthin (12 mg/d for 12 mo) had no effect on arterial stiffness, oxidative stress, or inflammation in

235 d pressure variability (P = .01), peripheral arterial stiffness (P = .02), carotid intima-media thick

236 Furthermore, patients demonstrated higher arterial stiffness (P = 0.005), LF and HF heart rate var

237 ng SLE patients, LV mass was associated with arterial stiffness (P<0.001).

238 tients with coronary heart disease (CHD) and arterial stiffness progression in young healthy subjects

239 nificantly and independently associated with arterial stiffness progression, incident subclinical ath

240 Quantitation of central arterial stiffness provides a modest increment in cardio

241 ustment for clinical factors known to modify arterial stiffness, proximal thoracic aortic stiffness w

242 Measures of arterial stiffness (pulse wave velocity [PWV] and augmen

243 se pressure (cPP), their relation to central arterial stiffness (pulse wave velocity [PWV]) and arter

244 na, heart failure, or stroke) in relation to arterial stiffness (pulse wave velocity [PWV]), wave ref

245 (laser Doppler imaging with iontophoresis), arterial stiffness (pulse wave velocity and analysis), b

246 Measures of arterial stiffness (pulse wave velocity and augmentation

247 monitor), renin and aldosterone levels, and arterial stiffness (pulse wave velocity and augmentation

248 icular mass (cardiac magnetic resonance) and arterial stiffness (pulse wave velocity/analysis, aortic

249 an 8.2 +/- 3.2% vs. 8.1 +/- 3.3%), and lower arterial stiffness (pulse wave velocity: mean 6.99 +/- 1

250 (laser Doppler imaging with iontophoresis), arterial stiffness [pulse wave velocity, pulse wave anal

251 fied the adverse effect of high total FMI on arterial stiffness (PWV 6.0 m/s [95% CI 5.9-6.0] for met

252 None of these arterial stiffness QTLs co-localized with previously rep

253 A demonstrated comparable relationships with arterial stiffness (r(2) = 0.616 for homocysteine and r(

254 Vascular function improved and arterial stiffness reduced in the arteries involved and

255 increased flow-mediated dilatation, reduced arterial stiffness, reduced mean arterial and diastolic

256 strongly related to pulse pressure and total arterial stiffness regardless of preload dependence stat

257 d systolic arterial pressures and with total arterial stiffness, regardless of the preload dependence

258 This suggests that arterial stiffness related to the presence of NAFLD is p

259 function, with increases in small and large arterial stiffness representing a characteristic change

260 bation frequency was related to stable-state arterial stiffness (rho = 0.209; P = 0.040).

261 Arterial stiffness rises acutely during COPD exacerbatio

262 Arterial stiffness rose by an average of 1.2 ms(-1) (11.

263 ular disease, factors capable of influencing arterial stiffness, such as exercise and the use of reni

264 anges at 3 and 6 mo in endothelial function, arterial stiffness, systemic-systolic BP, lipids, and in

265 than those with CRI (P < 0.001) and greater arterial stiffness than both CRI patients and control su

266 Frequent COPD exacerbators have greater arterial stiffness than infrequent exacerbators.

267 evalence of left ventricular hypertrophy and arterial stiffness that confer an adverse prognosis.

268 ologic and biophysical principles related to arterial stiffness, the impact of aortic stiffening on t

269 ce imaging assessment of cardiac morphology, arterial stiffness (total aortic compliance and arterial

270 ess index (ASI) is a non-invasive measure of arterial stiffness using infra-red finger sensors (photo

271 In a subsample (n = 42), cPP, arterial stiffness (using pulse wave velocity [PWV]) and

272 aser Doppler imaging with iontophoresis, and arterial stiffness, using pulse wave analysis.

273 osclerosis is, in part, related to increased arterial stiffness, vascular dysfunction, elevated oxida

274 erosols using animal models caused increased arterial stiffness, vascular endothelial changes, increa

275 greater insight into hemodynamics of altered arterial stiffness versus impaired peripheral resistance

276 Arterial stiffness was assessed in two medical examinati

277 absence of other factors known to influence arterial stiffness was assessed.

278 To look at effects on subclinical disease, arterial stiffness was evaluated at baseline and after 5

279 Arterial stiffness was increased in ExDHF dogs.

280 pheral (carotid-radial artery PWV, PWV(CR) ) arterial stiffness was measured by pulse-wave velocity (

281 Central arterial stiffness was measured via aortic pulse wave ve

282 Arterial stiffness was measured with a noninvasive and a

283 Pulse wave velocity (index of arterial stiffness) was also increased.

284 n of arterial pulse pressure (a surrogate of arterial stiffness) was linked to deterioration of the w

285 duction in pulse-wave velocity, a measure of arterial stiffness, was associated with a decrease in AD

286 2 peak ), whole body insulin sensitivity and arterial stiffness were also assessed.

287 Blood pressure, weight, and arterial stiffness were also measured.

288 Moreover, lipid concentrations and arterial stiffness were also unaffected by the intervent

289 and radial applanation tonometry to measure arterial stiffness were evaluated in SLE patients.

290 tress markers (glutathione and cystine), and arterial stiffness were evaluated.

291 T or BP, clinically relevant improvements in arterial stiffness were observed; equol producers were p

292 The measures of arterial stiffness were the carotid femoral pulse wave v

293 gether with augmentation index, a measure of arterial stiffness, were determined before and at interv

294 echniques for estimating the many aspects of arterial stiffness which are not fully understood.

295 Vascular aging is linked to increased arterial stiffness, which can be measured by PPG.

296 Arterial stiffness, which is a measure of arterial aging

297 CD8+ T-cells are associated with HIV-related arterial stiffness, which remains elevated during the fi

298 igate the association of local and segmental arterial stiffness with incident cardiovascular events a

299 derives performance improvement in assessing arterial stiffness, with a stronger correlation with cfP

300 elected nucleotide excision repair genes and arterial stiffness within the AortaGen Consortium and fo